Cite

HARVARD Citation

    Zhao, C. et al. (2022). Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis. Chinese medical journal. 135 (7), pp. 866-868. [Online]. 
  
Back to record